Top 10 Biotechnology Angel Investors in Estonia (October 2026)

Portfolio highlights

• YuMuuv — YuMuuv is an employee wellness platform that uses science-based formulas to capture data and keeps track of physical activity & leaderboard.
• Antegenes — Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations for personalized cancer prevention. The tests are based on innovative polygenic risk score technology which helps to clarify a person’s genetic predispositions to cancer. It therefore allows for more accurate prevention and early detectionmeasures – crucial in the fight with cancer. The tests are currently being used to determine the genetic risk for four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.
• Bidrento — One powerful platform for your entire portfolio. The leading property and tenant management software. Scale your operations and maximize your profit with Bidrento. Try it already today!

Portfolio highlights

• Efenco — Efenco is a deep-tech startup developing patented clean energy conversion technologies, that increase the combustion efficiency of natural gas and hydrogen by unprecedented 18%
• Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.
• Nordic Automation Systems — Nordic Automation Systems (NAS) is an industrial automation company. We believe in the world with precise data and less tedious repetitive manual tasks. We create sensor technologies, data analysis and monitoring solutions.LoRa® technology enables us to provide end-to-end LoRaWAN™ - smart metering, smart monitoring, smart city and industrialIoT applications. NAS has about 25 employees in it's Norwegian and Estonian offices and customers in every continent.

Portfolio highlights

• Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.

Portfolio highlights

• Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.

Portfolio highlights

• Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.

Portfolio highlights

• Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.

Portfolio highlights

• Gearbox Biosciences — A biotechnology company that licenses novel antibiotic-free recombinant protein production technology in E. coli.

Portfolio highlights

• Antegenes — Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations for personalized cancer prevention. The tests are based on innovative polygenic risk score technology which helps to clarify a person’s genetic predispositions to cancer. It therefore allows for more accurate prevention and early detectionmeasures – crucial in the fight with cancer. The tests are currently being used to determine the genetic risk for four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.
• Bisly — Bisly is an Estonian startup developing intelligent building solutions.
• Bidrento — One powerful platform for your entire portfolio. The leading property and tenant management software. Scale your operations and maximize your profit with Bidrento. Try it already today!

Portfolio highlights

• Patchstack — Keep your WordPress sites and JavaScript apps safe from vulnerable plugins, themes & npm packages. Protect sites with virtual patching.
• Nora AI — Nora AI offers a course for antiviral drug discovery by focusing on host cells. Nora provides scientists with profound insights into disease mechanisms and spotlights high-potential drug candidates.
• DriveX Technologies — Decrease your average claim size with AI vehicle inspection tool for CASCO pre-checks and windshield claims.

Portfolio highlights

• Antegenes — Antegenes’ novel genetic tests assess a patient’s personal cancer risks, and include clinical recommendations for personalized cancer prevention. The tests are based on innovative polygenic risk score technology which helps to clarify a person’s genetic predispositions to cancer. It therefore allows for more accurate prevention and early detectionmeasures – crucial in the fight with cancer. The tests are currently being used to determine the genetic risk for four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.